Entity Details

Primary name JAM2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP57087
EntryNameJAM2_HUMAN
FullNameJunctional adhesion molecule B
TaxID9606
Evidenceevidence at protein level
Length298
SequenceStatuscomplete
DateCreated2000-12-01
DateModified2021-06-02

Ontological Relatives

GenesJAM2

GO terms

Show/Hide Table
GOName
GO:0005178 integrin binding
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005923 bicellular tight junction
GO:0007286 spermatid development
GO:0007520 myoblast fusion
GO:0009986 cell surface
GO:0030198 extracellular matrix organization
GO:0031642 negative regulation of myelination
GO:0035633 maintenance of blood-brain barrier
GO:0036477 somatodendritic compartment
GO:0044291 cell-cell contact zone
GO:0045123 cellular extravasation
GO:0050900 leukocyte migration
GO:0050901 leukocyte tethering or rolling
GO:0070160 tight junction
GO:0071593 lymphocyte aggregation
GO:0097241 hematopoietic stem cell migration to bone marrow
GO:0098609 cell-cell adhesion
GO:0098636 protein complex involved in cell adhesion
GO:2000403 positive regulation of lymphocyte migration

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR003598 Immunoglobulin subtype 2DomainDomain
IPR003599 Immunoglobulin subtypeDomainDomain
IPR007110 Immunoglobulin-like domainDomainDomain
IPR013106 Immunoglobulin V-set domainDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR036179 Immunoglobulin-like domain superfamilyFamilyHomologous superfamily
IPR042625 Junctional adhesion molecule BFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618824 OMIMBasal ganglia calcification, idiopathic, 8, autosomal recessive (IBGC8)A form of basal ganglia calcification, a genetically heterogeneous condition characterized by symmetric calcification in the basal ganglia and other brain regions. Affected individuals can either be asymptomatic or show a wide spectrum of neuropsychiatric symptoms, including parkinsonism, dystonia, tremor, ataxia, dementia, psychosis, seizures, and chronic headache. Serum levels of calcium, phosphate, alkaline phosphatase and parathyroid hormone are normal. The neuropathological hallmark of the disease is vascular and pericapillary calcification, mainly of calcium phosphate, in the affected brain areas. The disease is caused by variants affecting the gene represented in this entry.